Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00475254 · ClinicalTrials.gov registry record

Stress and Vision Fluctuations in Retinitis Pigmentosa

A clinical trial, sponsored by Johns Hopkins University.

Completed
Registry status
50
Enrollment target

NCT00475254: Completed study, sponsored by Johns Hopkins University.

NCT00475254 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00475254 has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

Retinitis pigmentosa (RP) patients experience a slowly progressive, unpredictable loss of vision which eventually leads to bare or no light perception, posing a continuous threat to patients' independence. Negative psychological states such as distress, sleepiness, anxiety and depression are common in RP patients due to the nature of this chronic, disabling disease. Psychophysical vision measures are more variable in legally blind RP subjects than in normally sighted individuals, and RP patients indicate that variations in vision are often related to stress. The primary goal of this research is to examine the vision fluctuations within and between days among RP patients using vision tests self-administered by patients through their home computers, and determine associations with factors such as perceived stress, mood states, sleepiness, or light exposure. The administration of questionnaires will allow us to gain some insight into which underlying psychological factors impact certain vision measures, allowing the design of future interventional research to attempt to reduce such factors. The aims of many future treatment clinical trials for RP will be to improve vision and/or reduce the rate of vision loss; thus the sources that lead to increased variability of vision need to be identified and alleviated to enable precise evaluation of interventions and improve patients' quality of life.

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2007-08
Est. Completion 2011-04
Johns Hopkins University

1,448 total trials

What the finished NCT00475254 record still lists

NCT00475254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00475254 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00475254 about?

NCT00475254 is a clinical study titled "Stress and Vision Fluctuations in Retinitis Pigmentosa". Retinitis pigmentosa (RP) patients experience a slowly progressive, unpredictable loss of vision which eventually leads to bare or no light perception, posing a continuous threat to patients' independence. Negative psychological states such as distress, sleepiness, anxiety and depression are common ...

What is the current status of trial NCT00475254?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2007-08. Estimated completion is 2011-04.

Who is sponsoring clinical trial NCT00475254?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00475254, the US trial registry maintained by the National Library of Medicine. NCT00475254 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.